Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Raspberry aqueous extract is a natural research compound derived from the fruit of *Rubus idaeus*. It is prepared by extracting raspberry powder in distilled water and contains a complex mixture of bioactive phytochemicals, including polyphenols (such as ellagic acid and anthocyanins), vitamin C, organic acids, flavonoids, and tannins. Preclinical studies have explored its potential therapeutic effects in metabolic-associated fatty liver disease (MAFLD), methotrexate-induced nephrotoxicity, and oral mucosal lesions. The extract exhibits antimicrobial activity against pathogens like *Streptococcus mutans* and *Candida albicans*, as well as antioxidant and anti-inflammatory properties through free radical scavenging and inhibition of protein denaturation. It is primarily used in academic research and is not currently a commercially developed pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on raspberry aqueous extract.